David Mou, MD, MBA, is a psychiatrist specializing in adult psychiatry with expertise in digital mental health. He serves as an attending psychiatrist and faculty member at Massachusetts General Hospital and Harvard Medical School, and is Director of the Innovations Council in the Massachusetts General Hospital Department of Psychiatry. He is also Chief Executive Officer of Cerebral. His clinical focus includes telepsychiatry and digital care delivery, crisis intervention and acute psychiatric evaluation, and consultation-liaison and measurement-based mental healthcare. Dr. Mou’s research interests center on digital phenotyping and smartphone-based monitoring in psychiatry, machine learning and natural language processing for mental health triage and crisis detection, and precision psychiatry enabled by data-driven technologies. His work is focused on integrating scientific evidence and modern technology to improve access, support earlier intervention, and advance more continuous models of psychiatric care. In addition to his academic and clinical leadership, Dr. Mou is the co-founder and former Chief Medical Officer of Valera Health and a member of the Forbes Business Council. His honors include recognition as LinkedIn’s Top 10 Under 35 for Healthcare and MedTech Boston’s 40 Under 40 for Healthcare Innovation, as well as distinctions including Paul & Daisy Soros Fellow for New Americans, Gates Scholar, Horatio Alger National Scholar, World Economic Forum Global Shaper, and Academy of Achievement member. He earned his MD from Harvard Medical School and his MBA from Harvard Business School, and completed his adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by the Blavatnik Fellowship in Life Science Entrepreneurship at Harvard Business School.
Attending Physician
Medical School
2009 – 2014
Residency
2014 – 2018
Fellowship
2018 – 2019